Cancer drug developer Curis now has the FDA’s blessing to resume one of two clinical trials that were paused in the spring following a patient death. Curis said Thursday that the FDA lifted the ...
CAMBRIDGE, Mass., March 28, 2023 /PRNewswire/ -- Blueprint Medicines Corporation (BPMC) today announced that the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback